Depression, not PTSD, was independently associated with cannabis dependence in combat veterans

Among Israeli combat veterans using cannabis, those screening positive for dependence used more cannabis weekly and had higher moral injury scores, with depression (AOR 1.98) but not PTSD independently predicting dependence.

Asper, Ariel et al.·Journal of substance abuse treatment·2022·Moderate EvidenceCross-Sectional
RTHC-03685Cross SectionalModerate Evidence2022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Veterans with cannabis dependence used significantly more cannabis per week and scored higher on moral injury "other" and "betrayal" subscales. After controlling for confounders, depression was significantly associated with dependence (AOR 1.98, 95% CI 1.05-3.72), while PTSD was not (AOR 1.19, 95% CI 0.56-2.54).

Key Numbers

Depression AOR: 1.98 (95% CI 1.05-3.72, p<0.05). PTSD AOR: 1.19 (95% CI 0.56-2.54, not significant). Dependent users consumed more grams per week and had higher moral injury scores.

How They Did This

Cross-sectional study of Israeli combat veterans discharged within the past 5 years. Compared those screening positive vs. negative for cannabis dependence on sociodemographic and clinical variables using SPSS.

Why This Research Matters

The finding that depression, not PTSD, independently predicted cannabis dependence in veterans challenges the common assumption that veterans use cannabis primarily to self-medicate PTSD.

The Bigger Picture

If depression is the key driver of cannabis dependence in veterans, treatment strategies should prioritize depression management alongside cannabis cessation support.

What This Study Doesn't Tell Us

Cross-sectional cannot determine causation. Screening tools rather than diagnostic interviews. Israeli military context may not generalize. Self-reported cannabis quantity.

Questions This Raises

  • ?Would treating depression first improve cannabis dependence outcomes in veterans?
  • ?Is the PTSD-CUD relationship truly non-significant, or underpowered in this sample?

Trust & Context

Key Stat:
Depression doubled odds of cannabis dependence; PTSD was not significant
Evidence Grade:
Appropriate statistical controls, but cross-sectional and screening-based diagnosis.
Study Age:
Published in 2022.
Original Title:
Sociodemographic and clinical correlates of cannabis dependence among Israeli combat veterans.
Published In:
Journal of substance abuse treatment, 139, 108786 (2022)
Database ID:
RTHC-03685

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

Do veterans use cannabis because of PTSD?

Surprisingly, PTSD was not independently associated with cannabis dependence in this study. Depression was the stronger predictor, nearly doubling the odds of dependence.

What else predicted cannabis dependence in veterans?

Higher weekly cannabis dosage and higher moral injury scores (particularly around betrayal) were associated with dependence, alongside depression.

Read More on RethinkTHC

Cite This Study

RTHC-03685·https://rethinkthc.com/research/RTHC-03685

APA

Asper, Ariel; Binenfeld, Elishav; Pshitizky, Harel; Feingold, Daniel. (2022). Sociodemographic and clinical correlates of cannabis dependence among Israeli combat veterans.. Journal of substance abuse treatment, 139, 108786. https://doi.org/10.1016/j.jsat.2022.108786

MLA

Asper, Ariel, et al. "Sociodemographic and clinical correlates of cannabis dependence among Israeli combat veterans.." Journal of substance abuse treatment, 2022. https://doi.org/10.1016/j.jsat.2022.108786

RethinkTHC

RethinkTHC Research Database. "Sociodemographic and clinical correlates of cannabis depende..." RTHC-03685. Retrieved from https://rethinkthc.com/research/asper-2022-sociodemographic-and-clinical-correlates

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.